showed a trendP = 0.08
Although VSG maintained lean mass, semaglutide showed a trend toward reduced lean mass compared with the sham group ( P = 0.08 at day 21 and P = 0.11 at day 42 ) ( Fig. 1E ).
Although VSG maintained lean mass, semaglutide showed a trend toward reduced lean mass compared with the sham group ( P = 0.08 at day 21 and P = 0.11 at day 42 ) ( Fig. 1E ).